Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Condition: Advanced or Metastatic Solid Malignancies · Sponsor: Mirati Therapeutics Inc.
About this study
A Study of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Advanced or Metastatic Malignancies
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (13)
| Rocky Mountain Cancer Centers - Littleton | Littleton, Colorado, United States | — |
| Local Institution - 516-014-029 | Goshen, Indiana, United States | — |
| Local Institution - 516-014-002 | Boston, Massachusetts, United States | — |
| Barbara Ann Karmanos Cancer Institute | Detroit, Michigan, United States | — |
| Local Institution - 516-014-005 | Minneapolis, Minnesota, United States | — |
| Urology Cancer Center and GU Research Network | Omaha, Nebraska, United States | — |
| Local Institution - 516-014-011 | Albany, New York, United States | — |
| Memorial Sloan Kettering Cancer Center - Arnold and Marie Schwartz Cancer Research Building | New York, New York, United States | — |
| Local Institution - 516-014-004 | Columbus, Ohio, United States | — |
| Local Institution - 516-014-001 | Austin, Texas, United States | — |
| USOR - Texas Oncology Northeast Texas - Denison | Denison, Texas, United States | — |
| Local Institution - 516-014-013 | Houston, Texas, United States | — |
+ 1 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04887870